_id
6919e4153c536f8df231806e
Ticker
AGY.LSE
Name
Allergy Therapeutics
Exchange
LSE
Address
Dominion Way, Worthing, United Kingdom, BN14 8SA
Country
UK
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
GBX
Website
https://www.allergytherapeutics.com
Description
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.
Last Close
113000
Volume
237917
Current Price
11.08
Change
0
Last Updated
2025-12-29T14:57:27.122Z
Image
https://logo.clearbit.com/www.allergytherapeutics.com
Ipo Date
-
Market Cap
690912000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
21014000
Cost Of Revenue
16746000
Gross Profit
4268000
Operating Expenses
26954000
Operating Income
-22587000
Interest Expense
3880000
Pretax Income
-29082000
Net Income
-29047000
Eps
-0.006094066074178892
Dividends Per Share
-
Shares Outstanding
6141439951
Income Tax Expense
-35000
EBITDA
-22965000
Operating Margin
-107.48548586656514
Total Other Income Expense Net
-6396000
Cash
12790000
Short Term Investments
-
Receivables
7972000
Inventories
13915000
Total Current Assets
34677000
Property Plant Equipment
24258000
Total Assets
67543000
Payables
4491000
Short Term Debt
1880000
Long Term Debt
53040000
Total Liabilities
95736000
Equity
-28193000
Bs_currency_symbol
GBP
Depreciation
2237000
Change In Working Capital
-570000
Cash From Operations
-21088000
Capital Expenditures
1740000
Cash From Investing
-1631000
Cash From Financing
14232000
Net Change In Cash
-8886000
Cf_currency_symbol
-
PE
-
PB
-1873.2364295066152
ROE
103.02912070372079
ROA
-43.0051966895163
FCF
-22828000
Fcf Percent
-1.0863234034453222
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
21014000
Quarters > 0 > income Statement > cost Of Revenue
16746000
Quarters > 0 > income Statement > gross Profit
4268000
Quarters > 0 > income Statement > operating Expenses
26954000
Quarters > 0 > income Statement > operating Income
-22587000
Quarters > 0 > income Statement > interest Expense
3880000
Quarters > 0 > income Statement > pretax Income
-29082000
Quarters > 0 > income Statement > net Income
-29047000
Quarters > 0 > income Statement > eps
-0.006094066074178892
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4766439951
Quarters > 0 > income Statement > income Tax Expense
-35000
Quarters > 0 > income Statement > EBITDA
-22965000
Quarters > 0 > income Statement > operating Margin
-107.48548586656514
Quarters > 0 > income Statement > total Other Income Expense Net
-6396000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
12790000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7972000
Quarters > 0 > balance Sheet > inventories
13915000
Quarters > 0 > balance Sheet > total Current Assets
34677000
Quarters > 0 > balance Sheet > property Plant Equipment
24258000
Quarters > 0 > balance Sheet > total Assets
67543000
Quarters > 0 > balance Sheet > payables
4491000
Quarters > 0 > balance Sheet > short Term Debt
1880000
Quarters > 0 > balance Sheet > long Term Debt
53040000
Quarters > 0 > balance Sheet > total Liabilities
95736000
Quarters > 0 > balance Sheet > equity
-28193000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-29047000
Quarters > 0 > cash Flow > depreciation
2237000
Quarters > 0 > cash Flow > change In Working Capital
-570000
Quarters > 0 > cash Flow > cash From Operations
-21088000
Quarters > 0 > cash Flow > capital Expenditures
1740000
Quarters > 0 > cash Flow > cash From Investing
-1631000
Quarters > 0 > cash Flow > cash From Financing
14232000
Quarters > 0 > cash Flow > net Change In Cash
-8886000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.006094066074178892
Quarters > 0 > ratios > PB
-1873.2364295066152
Quarters > 0 > ratios > ROE
103.02912070372079
Quarters > 0 > ratios > ROA
-43.0051966895163
Quarters > 0 > ratios > FCF
-22828000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.0863234034453222
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
34030000
Quarters > 1 > income Statement > cost Of Revenue
13168000
Quarters > 1 > income Statement > gross Profit
20862000
Quarters > 1 > income Statement > operating Expenses
27681000
Quarters > 1 > income Statement > operating Income
-6819000
Quarters > 1 > income Statement > interest Expense
2963000
Quarters > 1 > income Statement > pretax Income
-11362000
Quarters > 1 > income Statement > net Income
-11085000
Quarters > 1 > income Statement > eps
-0.002325635065163938
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4766440000
Quarters > 1 > income Statement > income Tax Expense
-277000
Quarters > 1 > income Statement > EBITDA
-6464000
Quarters > 1 > income Statement > operating Margin
-20.038201586835143
Quarters > 1 > income Statement > total Other Income Expense Net
-4543000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
21676000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
8615000
Quarters > 1 > balance Sheet > inventories
11874000
Quarters > 1 > balance Sheet > total Current Assets
42165000
Quarters > 1 > balance Sheet > property Plant Equipment
23315000
Quarters > 1 > balance Sheet > total Assets
72970000
Quarters > 1 > balance Sheet > payables
14233000
Quarters > 1 > balance Sheet > short Term Debt
3405000
Quarters > 1 > balance Sheet > long Term Debt
36959000
Quarters > 1 > balance Sheet > total Liabilities
80120000
Quarters > 1 > balance Sheet > equity
-7150000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-11085000
Quarters > 1 > cash Flow > depreciation
1935000
Quarters > 1 > cash Flow > change In Working Capital
-2764000
Quarters > 1 > cash Flow > cash From Operations
-7629000
Quarters > 1 > cash Flow > capital Expenditures
1524000
Quarters > 1 > cash Flow > cash From Investing
-1524000
Quarters > 1 > cash Flow > cash From Financing
17808000
Quarters > 1 > cash Flow > net Change In Cash
8761000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.002325635065163938
Quarters > 1 > ratios > PB
-7386.3154125874125
Quarters > 1 > ratios > ROE
155.03496503496504
Quarters > 1 > ratios > ROA
-15.191174455255585
Quarters > 1 > ratios > FCF
-9153000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.2689685571554511
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
21627000
Quarters > 2 > income Statement > cost Of Revenue
12410000
Quarters > 2 > income Statement > gross Profit
9217000
Quarters > 2 > income Statement > operating Expenses
32535000
Quarters > 2 > income Statement > operating Income
-23318000
Quarters > 2 > income Statement > interest Expense
1005000
Quarters > 2 > income Statement > pretax Income
-24250000
Quarters > 2 > income Statement > net Income
-24565000
Quarters > 2 > income Statement > eps
-0.006535843944269547
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3758504672
Quarters > 2 > income Statement > income Tax Expense
315000
Quarters > 2 > income Statement > EBITDA
-21040000
Quarters > 2 > income Statement > operating Margin
-107.81893004115226
Quarters > 2 > income Statement > total Other Income Expense Net
-932000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
12915000
Quarters > 2 > balance Sheet > short Term Investments
200000
Quarters > 2 > balance Sheet > receivables
7823000
Quarters > 2 > balance Sheet > inventories
12744000
Quarters > 2 > balance Sheet > total Current Assets
33482000
Quarters > 2 > balance Sheet > property Plant Equipment
23745000
Quarters > 2 > balance Sheet > total Assets
64827000
Quarters > 2 > balance Sheet > payables
4015000
Quarters > 2 > balance Sheet > short Term Debt
2116000
Quarters > 2 > balance Sheet > long Term Debt
22500000
Quarters > 2 > balance Sheet > total Liabilities
61118000
Quarters > 2 > balance Sheet > equity
3709000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-24565000
Quarters > 2 > cash Flow > depreciation
2205000
Quarters > 2 > cash Flow > change In Working Capital
81000
Quarters > 2 > cash Flow > cash From Operations
-21854000
Quarters > 2 > cash Flow > capital Expenditures
1536000
Quarters > 2 > cash Flow > cash From Investing
531000
Quarters > 2 > cash Flow > cash From Financing
20803000
Quarters > 2 > cash Flow > net Change In Cash
-607000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.006535843944269547
Quarters > 2 > ratios > PB
11227.88669877595
Quarters > 2 > ratios > ROE
-662.3078997034241
Quarters > 2 > ratios > ROA
-37.893161799867336
Quarters > 2 > ratios > FCF
-23390000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0815184722800204
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
33572000
Quarters > 3 > income Statement > cost Of Revenue
13052000
Quarters > 3 > income Statement > gross Profit
20520000
Quarters > 3 > income Statement > operating Expenses
32406000
Quarters > 3 > income Statement > operating Income
-11886000
Quarters > 3 > income Statement > interest Expense
3189000
Quarters > 3 > income Statement > pretax Income
-14916000
Quarters > 3 > income Statement > net Income
-15651000
Quarters > 3 > income Statement > eps
-0.005753570294211065
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2720224000
Quarters > 3 > income Statement > income Tax Expense
735000
Quarters > 3 > income Statement > EBITDA
-9700000
Quarters > 3 > income Statement > operating Margin
-35.40450375312761
Quarters > 3 > income Statement > total Other Income Expense Net
-3030000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
13522000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
9934000
Quarters > 3 > balance Sheet > inventories
11893000
Quarters > 3 > balance Sheet > total Current Assets
35349000
Quarters > 3 > balance Sheet > property Plant Equipment
23392000
Quarters > 3 > balance Sheet > total Assets
69077000
Quarters > 3 > balance Sheet > payables
20088000
Quarters > 3 > balance Sheet > short Term Debt
1750000
Quarters > 3 > balance Sheet > long Term Debt
948000
Quarters > 3 > balance Sheet > total Liabilities
42615000
Quarters > 3 > balance Sheet > equity
26462000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-7825500
Quarters > 3 > cash Flow > depreciation
2114000
Quarters > 3 > cash Flow > change In Working Capital
-388000
Quarters > 3 > cash Flow > cash From Operations
-10774000
Quarters > 3 > cash Flow > capital Expenditures
1865000
Quarters > 3 > cash Flow > cash From Investing
-1796000
Quarters > 3 > cash Flow > cash From Financing
11184000
Quarters > 3 > cash Flow > net Change In Cash
-1323000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.005753570294211065
Quarters > 3 > ratios > PB
1138.9948575315548
Quarters > 3 > ratios > ROE
-59.14518932809312
Quarters > 3 > ratios > ROA
-22.65732443505074
Quarters > 3 > ratios > FCF
-12639000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.3764744429882045
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
55044000
Annuals > 0 > income Statement > cost Of Revenue
29914000
Annuals > 0 > income Statement > gross Profit
25130000
Annuals > 0 > income Statement > operating Expenses
54635000
Annuals > 0 > income Statement > operating Income
-29505000
Annuals > 0 > income Statement > interest Expense
6843000
Annuals > 0 > income Statement > pretax Income
-40444000
Annuals > 0 > income Statement > net Income
-40132000
Annuals > 0 > income Statement > eps
-0.008419701076694557
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4766440000
Annuals > 0 > income Statement > income Tax Expense
-312000
Annuals > 0 > income Statement > EBITDA
-29429000
Annuals > 0 > income Statement > operating Margin
-53.60257248746457
Annuals > 0 > income Statement > total Other Income Expense Net
-10939000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
12790000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
7972000
Annuals > 0 > balance Sheet > inventories
13915000
Annuals > 0 > balance Sheet > total Current Assets
34677000
Annuals > 0 > balance Sheet > property Plant Equipment
24258000
Annuals > 0 > balance Sheet > total Assets
67543000
Annuals > 0 > balance Sheet > payables
4491000
Annuals > 0 > balance Sheet > short Term Debt
1880000
Annuals > 0 > balance Sheet > long Term Debt
53040000
Annuals > 0 > balance Sheet > total Liabilities
95736000
Annuals > 0 > balance Sheet > equity
-28193000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-39200000
Annuals > 0 > cash Flow > depreciation
4172000
Annuals > 0 > cash Flow > change In Working Capital
-3334000
Annuals > 0 > cash Flow > cash From Operations
-28717000
Annuals > 0 > cash Flow > capital Expenditures
3264000
Annuals > 0 > cash Flow > cash From Investing
-3155000
Annuals > 0 > cash Flow > cash From Financing
32040000
Annuals > 0 > cash Flow > net Change In Cash
-125000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.008419701076694557
Annuals > 0 > ratios > PB
-1870.8695435037068
Annuals > 0 > ratios > ROE
142.34739119639627
Annuals > 0 > ratios > ROA
-59.41696400811335
Annuals > 0 > ratios > FCF
-31981000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.5810079209359785
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
55199000
Annuals > 1 > income Statement > cost Of Revenue
25462000
Annuals > 1 > income Statement > gross Profit
29737000
Annuals > 1 > income Statement > operating Expenses
64994000
Annuals > 1 > income Statement > operating Income
-35257000
Annuals > 1 > income Statement > interest Expense
3877000
Annuals > 1 > income Statement > pretax Income
-39166000
Annuals > 1 > income Statement > net Income
-40216000
Annuals > 1 > income Statement > eps
-0.010743369810639291
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3743332000
Annuals > 1 > income Statement > income Tax Expense
1050000
Annuals > 1 > income Statement > EBITDA
-30740000
Annuals > 1 > income Statement > operating Margin
-63.87253392271599
Annuals > 1 > income Statement > total Other Income Expense Net
-3909000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
12915000
Annuals > 1 > balance Sheet > short Term Investments
200000
Annuals > 1 > balance Sheet > receivables
7823000
Annuals > 1 > balance Sheet > inventories
12744000
Annuals > 1 > balance Sheet > total Current Assets
33482000
Annuals > 1 > balance Sheet > property Plant Equipment
23745000
Annuals > 1 > balance Sheet > total Assets
64827000
Annuals > 1 > balance Sheet > payables
4015000
Annuals > 1 > balance Sheet > short Term Debt
2116000
Annuals > 1 > balance Sheet > long Term Debt
22500000
Annuals > 1 > balance Sheet > total Liabilities
61118000
Annuals > 1 > balance Sheet > equity
3709000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-40216000
Annuals > 1 > cash Flow > depreciation
4319000
Annuals > 1 > cash Flow > change In Working Capital
-1095000
Annuals > 1 > cash Flow > cash From Operations
-32138000
Annuals > 1 > cash Flow > capital Expenditures
3401000
Annuals > 1 > cash Flow > cash From Investing
-1199000
Annuals > 1 > cash Flow > cash From Financing
31431000
Annuals > 1 > cash Flow > net Change In Cash
-1930000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.010743369810639291
Annuals > 1 > ratios > PB
11168.431359396065
Annuals > 1 > ratios > ROE
-1084.2814774871933
Annuals > 1 > ratios > ROA
-62.03588011168186
Annuals > 1 > ratios > FCF
-35539000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.6438341274298447
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
59587000
Annuals > 2 > income Statement > cost Of Revenue
26896000
Annuals > 2 > income Statement > gross Profit
32691000
Annuals > 2 > income Statement > operating Expenses
72899000
Annuals > 2 > income Statement > operating Income
-34851000
Annuals > 2 > income Statement > interest Expense
2441000
Annuals > 2 > income Statement > pretax Income
-42622000
Annuals > 2 > income Statement > net Income
-43071000
Annuals > 2 > income Statement > eps
-0.0642510311700517
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
670355000
Annuals > 2 > income Statement > income Tax Expense
1305000
Annuals > 2 > income Statement > EBITDA
-36240000
Annuals > 2 > income Statement > operating Margin
-58.48758957490728
Annuals > 2 > income Statement > total Other Income Expense Net
-7771000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
14845000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
7088000
Annuals > 2 > balance Sheet > inventories
11593000
Annuals > 2 > balance Sheet > total Current Assets
33526000
Annuals > 2 > balance Sheet > property Plant Equipment
23241000
Annuals > 2 > balance Sheet > total Assets
66769000
Annuals > 2 > balance Sheet > payables
4090000
Annuals > 2 > balance Sheet > short Term Debt
1803000
Annuals > 2 > balance Sheet > long Term Debt
26848000
Annuals > 2 > balance Sheet > total Liabilities
64703000
Annuals > 2 > balance Sheet > equity
2066000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-43071000
Annuals > 2 > cash Flow > depreciation
4224000
Annuals > 2 > cash Flow > change In Working Capital
8015000
Annuals > 2 > cash Flow > cash From Operations
-30916000
Annuals > 2 > cash Flow > capital Expenditures
4669000
Annuals > 2 > cash Flow > cash From Investing
-4669000
Annuals > 2 > cash Flow > cash From Financing
29913000
Annuals > 2 > cash Flow > net Change In Cash
-5670000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.0642510311700517
Annuals > 2 > ratios > PB
3590.5849128751215
Annuals > 2 > ratios > ROE
-2084.7531461761855
Annuals > 2 > ratios > ROA
-64.50748101663946
Annuals > 2 > ratios > FCF
-35585000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.5971940188296105
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
72768000
Annuals > 3 > income Statement > cost Of Revenue
23814000
Annuals > 3 > income Statement > gross Profit
48954000
Annuals > 3 > income Statement > operating Expenses
61955000
Annuals > 3 > income Statement > operating Income
-13001000
Annuals > 3 > income Statement > interest Expense
541000
Annuals > 3 > income Statement > pretax Income
-13397000
Annuals > 3 > income Statement > net Income
-13776000
Annuals > 3 > income Statement > eps
-0.021424905519525965
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
642990000
Annuals > 3 > income Statement > income Tax Expense
1119000
Annuals > 3 > income Statement > EBITDA
-8690000
Annuals > 3 > income Statement > operating Margin
-17.866369832893582
Annuals > 3 > income Statement > total Other Income Expense Net
-396000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
20515000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
10468000
Annuals > 3 > balance Sheet > inventories
11410000
Annuals > 3 > balance Sheet > total Current Assets
42393000
Annuals > 3 > balance Sheet > property Plant Equipment
20190000
Annuals > 3 > balance Sheet > total Assets
72948000
Annuals > 3 > balance Sheet > payables
4282000
Annuals > 3 > balance Sheet > short Term Debt
2268000
Annuals > 3 > balance Sheet > long Term Debt
1497000
Annuals > 3 > balance Sheet > total Liabilities
35183000
Annuals > 3 > balance Sheet > equity
37765000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-13776000
Annuals > 3 > cash Flow > depreciation
4166000
Annuals > 3 > cash Flow > change In Working Capital
-5885000
Annuals > 3 > cash Flow > cash From Operations
-14111000
Annuals > 3 > cash Flow > capital Expenditures
3056000
Annuals > 3 > cash Flow > cash From Investing
-3056000
Annuals > 3 > cash Flow > cash From Financing
-2638000
Annuals > 3 > cash Flow > net Change In Cash
-19758000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.021424905519525965
Annuals > 3 > ratios > PB
188.41062730041045
Annuals > 3 > ratios > ROE
-36.47822057460612
Annuals > 3 > ratios > ROA
-18.884684981082415
Annuals > 3 > ratios > FCF
-17167000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.2359141380826737
Annuals > 3 > health Score
23
Valuation > metrics > PE
-0.006094066074178892
Valuation > metrics > PB
-1873.2364295066152
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
103.02912070372079
Profitability > metrics > ROA
-83.76445482596534
Profitability > metrics > Net Margin
-1.3822689635481107
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-5.82139175257732
Risk > final Score
7
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.442944592685607
Liquidity > metrics > Quick Ratio
3.2588290692199027
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
21
Prev Risks > 1
-87
Prev Risks > 2
15
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
90
Updated At
2026-01-20T22:59:42.204Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-30
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-11
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0052
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0052
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-30
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-29
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.03
Earnings History > 4 > eps Estimate
-2
Earnings History > 4 > eps Difference
1.97
Earnings History > 4 > surprise Percent
98.5
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-03
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-23
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.02
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-01
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0.02
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-23
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-04
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0.02
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-25
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
-1.41
Earnings History > 10 > eps Difference
1.4
Earnings History > 10 > surprise Percent
99.2908
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-06
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0.02
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.02
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-26
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.02
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-07
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0.01
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-06-30
Earnings History > 14 > report Date
2017-09-28
Earnings History > 14 > date
2017-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.02
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-03-06
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-26
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.02
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2015-12-31
Earnings History > 17 > report Date
2016-03-08
Earnings History > 17 > date
2015-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2015-06-30
Earnings History > 18 > report Date
2015-09-22
Earnings History > 18 > date
2015-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2014-12-31
Earnings History > 19 > report Date
2015-03-02
Earnings History > 19 > date
2014-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2014-06-30
Earnings History > 20 > report Date
2014-09-22
Earnings History > 20 > date
2014-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2013-12-31
Earnings History > 21 > report Date
2014-03-24
Earnings History > 21 > date
2013-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMinister of Finance Rings Opening Bell at London Stock Exchange to Mark Launch of "Qatar Day" Qatar news agency
Read more →Wood Group shares surge on return to LSE trading ahead of Sidara vote - Scottish Financial News
11/6/2025
Wood Group shares surge on return to LSE trading ahead of Sidara vote Scottish Financial News
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Allergy Therapeutics
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0052
EPS Estimate
0
EPS Difference
-0.0052
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
ÂŁ 0
Cost Of Revenue
ÂŁ 0
Gross Profit
ÂŁ 0
Operating Expenses
ÂŁ 0
Operating Income
ÂŁ 0
Interest Expense
ÂŁ 0
Pretax Income
ÂŁ 0
Net Income
ÂŁ 0
Income Tax Expense
ÂŁ 0
EBITDA
ÂŁ 0
Total Other Income Expense Net
ÂŁ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
ÂŁ 0
Short Term Investments
ÂŁ 0
Receivables
ÂŁ 0
Inventories
ÂŁ 0
Total Current Assets
ÂŁ 0
Property Plant Equipment
ÂŁ 0
Total Assets
ÂŁ 0
Payables
ÂŁ 0
Short Term Debt
ÂŁ 0
Long Term Debt
ÂŁ 0
Total Liabilities
ÂŁ 0
Equity
ÂŁ 0
(Last Updated 2025-06-30)
Net Income
ÂŁ 0
Depreciation
ÂŁ 0
Change In Working Capital
ÂŁ 0
Cash From Operations
ÂŁ 0
Capital Expenditures
ÂŁ 0
Cash From Investing
ÂŁ 0
Cash From Financing
ÂŁ 0
Net Change In Cash
ÂŁ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.